Linda Kozick
Director/Board Member chez RAPT THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Linda M.
Kozick is an Independent Director at Portage Biotech, Inc., Rapt Therapeutics, Inc., and Artiva Biotherapeutics, Inc. She is also a Director at Saugatuck Therapeutics, Ltd.
Previously, she worked as VP, Head-Immuno Oncology & Oncology Product at Bristol Myers Squibb Co. from 2011 to 2015.
Kozick holds an MBA from Chapman University and undergraduate and graduate degrees from SUNY Upstate Medical University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
RAPT THERAPEUTICS, INC.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
PORTAGE BIOTECH INC
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Linda Kozick
Sociétés | Poste | Début |
---|---|---|
RAPT THERAPEUTICS, INC. | Director/Board Member | 01/12/2016 |
PORTAGE BIOTECH INC. | Director/Board Member | 15/02/2022 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 19/05/2021 |
Saugatuck Therapeutics, Ltd. | Director/Board Member | - |
Anciens postes connus de Linda Kozick
Sociétés | Poste | Fin |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/07/2015 |
Formation de Linda Kozick
Chapman University | Masters Business Admin |
SUNY Upstate Medical University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
PORTAGE BIOTECH INC. | Health Technology |
RAPT THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
Saugatuck Therapeutics, Ltd. |